The clinician's prescribing decision is final, payment does not guarantee a prescription, and any decision about whether to start, continue, or stop a GLP-1 treatment should be made in consultation with a qualified licensed healthcare professional
Although its anti-inflammatory properties may contribute to OSAS improvement, the complexity of immune regulation raises the possibility of unforeseen immune-related effects
The litigation alleges manufacturers set out to create and expand markets by advocating for obesity classification as a disease, thereby justifying pharmaceutical intervention and insurance coverage
Li L, Stillemark-Billton P, Beck C, Bostrom P, Andersson L, et al
And some normal weight women are actually carrying inflammatory visceral fat the scale never shows
John Burns explains this FDA-cleared technology and answers common post-Ozempic body contouring questions